Moderna, Inc.
MRNANASDAQHealthcare● Active
$47.60
+$0.16(+0.34%)
Market Cap$18.9B
P/E Ratio—
52W High$59.55
52W Low$22.28
Moderna, Inc. (MRNA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MRNA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.94B | $3.20B | $6.85B | $18.88B | $17.74B |
| Cost of Revenue | $0.87B | $1.46B | $4.69B | $5.42B | $2.62B |
| Gross Profit | $1.08B | $1.74B | $2.15B | $13.46B | $15.12B |
| Gross Margin %(computed) | 55.35% | 54.24% | 31.47% | 71.31% | 85.24% |
| Operating Expenses | |||||
| R&D Expenses | $3.13B | $4.54B | $4.84B | $3.29B | $1.99B |
| G&A Expenses | $0.00B | $1.03B | $1.34B | $1.01B | $0.00B |
| Total Operating Expenses | $4.15B | $5.68B | $6.39B | $4.04B | $1.82B |
| Operating Income | ($3.07B) | ($3.94B) | ($4.24B) | $9.42B | $13.30B |
| Operating Margin %(computed) | -158.13% | -123.32% | -61.90% | 49.91% | 74.97% |
| Interest Income | $0.31B | $0.42B | $0.42B | $0.20B | $0.02B |
| Interest Expense | $0.00B | $0.02B | $0.04B | $0.03B | $0.02B |
| Income Before Tax | ($2.77B) | ($3.61B) | ($3.94B) | $9.57B | $13.29B |
| Income Tax Expense | $0.05B | ($0.05B) | $0.77B | $1.21B | $1.08B |
| Net Income | ($2.82B) | ($3.56B) | ($4.71B) | $8.36B | $12.20B |
| Net Margin %(computed) | -145.16% | -111.32% | -68.84% | 44.30% | 68.80% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.26 | $-9.27 | $-12.34 | $21.26 | $30.31 |
| Wtd Avg Shares | 0.39B | 0.38B | 0.38B | 0.39B | 0.40B |
| EBITDA | ($2.55B) | ($3.39B) | ($3.28B) | $9.77B | $13.53B |
| EBITDA Margin %(computed) | -131.33% | -106.10% | -47.94% | 51.75% | 76.27% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Moderna, Inc. data
About Moderna, Inc. (MRNA) Income Statement
Moderna, Inc. (MRNA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MRNA reported revenue of $1.94B, gross profit of $1.08B (gross margin 55.35%), and net income of ($2.82B) — a net profit margin of -145.16%.
Frequently asked questions
MRNA · 4 questionsModerna, Inc. (MRNA) reported revenue of $1.94B for 2025, down 39.2% year-over-year.
MRNA revenueMRNA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08